Home › Funds › Point72 Asset Management › ENTA
Point72 Asset Management position in ENTA
ENANTA PHARMACEUTICALS INC · Health Care
Latest position (Q4 2025)438.94K sh
Reported value held$6.92M
Portfolio Weight0.01%
First reportedQ2 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 28.70K | $1.36M | New |
| Q1 2023 | 11.97K | $483.99K | New |
| Q2 2023 | 8.20K | $175.48K | Reduce |
| Q3 2023 | 25.93K | $289.66K | Add |
| Q3 2024 | 87.19K | $903.29K | New |
| Q3 2025 | 300.00K | $3.59M | New |
| Q4 2025 | 438.94K | $6.92M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ENTA
- Janus Henderson Group 3.78M sh · $47.72M · Q1 2026
- BlackRock Inc 3.24M sh · $47.30M · Q2 2026
- Vanguard Group 2.30M sh · $36.30M · Q4 2025
- Farallon Capital Management 2.42M sh · $35.26M · Q2 2026
- Geode Capital Management 776.63K sh · $11.33M · Q2 2026
- Millennium Management 643.97K sh · $9.39M · Q2 2026
- Renaissance Technologies 557.60K sh · $8.13M · Q2 2026
- Goldman Sachs Group 464.65K sh · $6.77M · Q2 2026
- Morgan Stanley 315.73K sh · $4.60M · Q2 2026
- Charles Schwab Investment Management 301.15K sh · $4.39M · Q2 2026
- Northern Trust Corp 259.70K sh · $3.79M · Q2 2026
- AQR Capital Management 256.87K sh · $3.75M · Q2 2026